In a strong show of support for H.R. 6, the 21st Century Cures Act, 67 AACI cancer centers signed a letter to House Energy and Commerce Committee Chairman Upton (R-MI) and Ranking Member Diana DeGette (D-CO), thanking them for their efforts on 21st Century Cures. The cancer centers expressed their support for the bipartisan way that Upton and DeGette united to improve and expedite the discovery, development, and delivery of care.
The cancer community was encouraged to see that H.R. 6 authorizes $1.5 billion per year in increased funding for the National Institutes of Health (NIH) over the next three years, and also language to provide an additional $10 billion in mandatory funding for the NIH Innovation Fund through Fiscal Year 2021. Cancer centers have struggled with flat funding from the NIH and National Cancer Institute (NCI) over the last several years.
Additionally, our nation’s cancer centers voiced their approval for language included in the bill to increase funding to the U.S. Food and Drug Administration (FDA) by $550 million over five years. Predictable and sustained growth in NIH and FDA funding remains a priority for the cancer community.
AACI’s cancer centers asked Chairman Upton and Ranking Member DeGette to ensure that the NIH Innovation Fund and the Cures Innovation Fund in the bill supplement, not supplant, the regular appropriations for the NIH and FDA.
The House Energy and Commerce Committee unanimously approved the bill 51-0 on May 21 and the bill has garnered 171 cosponsors. H.R. 6 could be brought to the House floor for a vote as early as next week.
AACI cancer centers are encouraged to contact their legislators and convey the following message(s):
- Please cosponsor H.R. 6, the 21st Century Cures Act
- Please vote yes on H.R. 6, the 21st Century Cures Act, when it comes to the House floor
Read the full letter submitted to Chairman Upton and Ranking Member DeGette.
– Jennifer W. Pegher, AACI Government Relations Manager